7-Nitroindazole, but not NG-nitro-L-arginine, enhances the anticonvulsant activity of pregabalin in the mouse maximal electroshock-induced seizure model

Pharmacological Reports

Volumn 63, Issue 1, 2011, Pages 169-175

  Łuszczki, Jarogniew J ^a,b   Jaskólska, Anna ^b   Dworzański, Wojciech ^b   Zółkowska, Dorota ^c  

^a INSTITUTE OF AGRICULTURAL MEDICINE   (Poland)

^b MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

7 Nitroindazole; Maximal electroshock seizure test; Nitric oxide; Pregabalin

Indexed keywords

7 NITROINDAZOLE; N(G) NITROARGININE; PREGABALIN; 4 AMINOBUTYRIC ACID; 7-NITROINDAZOLE; ANTICONVULSIVE AGENT; DRUG DERIVATIVE; ENZYME INHIBITOR; INDAZOLE DERIVATIVE; NEUROPROTECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG POTENTIATION; ELECTRIC SHOCK; GRIP STRENGTH; LONG TERM MEMORY; MALE; MONOTHERAPY; MOTOR COORDINATION; MOUSE; NONHUMAN; PASSIVE AVOIDANCE; SEIZURE; ANIMAL; DISEASE MODEL; DRUG COMBINATION; TOXICITY TESTING;

ACUTE TOXICITY TESTS; ANIMALS; ANTICONVULSANTS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; ELECTROSHOCK; ENZYME INHIBITORS; GAMMA-AMINOBUTYRIC ACID; INDAZOLES; MALE; MICE; NEUROPROTECTIVE AGENTS; NITROARGININE; SEIZURES;

EID: 79953205977     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/s1734-1140(11)70412-1     Document Type: Article

References (35)

1. Babbedge RC, Bland-Ward PA, Hart SL, Moore PK: Inhibition of rat cerebellar nitric oxide synthase by 7-nitro indazole and related substituted indazoles. Br J Pharmacol, 1993, 110, 225-228.
2. Baran L, Siwanowicz J, Przegaliński E: Effect of nitric oxide synthase inhibitors and molsidomine on the anti-convulsant activity of some antiepileptic drugs. Pol J Pharmacol, 1997, 49, 363-368.
3. Ben-Menachem E: Pregabalin pharmacology and its relevance to clinical practice. Epilepsia, 2004, 45, Suppl 6, 13-18.
4. 2-delta type 1 genetically modified mice. Brain Res, 2006, 1075, 68-80.
5. Boissier JR, Tardy J, Diverres JC: A simple novel method to explore tranquilizer activity: the chimney test (French). Med Exp (Basel), 1960, 3, 81-84.
6. Borowicz KK, Kleinrok Z, Czuczwar SJ: Influence of 7-nitroindazole on the anticonvulsive action of conventional antiepileptic drugs. Eur J Pharmacol, 1997, 331, 127-132.
7. Borowicz KK, Łuszczki J, Kleinrok Z, Czuczwar SJ: 7- Nitroindazole, a nitric oxide synthase inhibitor, enhances the anticonvulsive action of ethosuximide and clonazepam against pentylenetetrazol-induced convulsions. J Neural Transm, 2000, 107, 1117-1126.
8. G-nitroarginine methyl ester, an inhibitor of nitric oxide synthase, upon the anticonvulsive activity of conventional antiepileptic drugs against maximal electroshock in mice. J Neural Transm, 1998, 105, 1-12.
9. Brodie MJ: Pregabalin as adjunctive therapy for partial seizures. Epilepsia, 2004, 45, Suppl 6, 19-27.
10. Gnitro- L-arginine impairs the anticonvulsive action of ethosuximide against pentylenetetrazol. Eur J Pharmacol, 1999, 366, 137-142.
11. De Sarro G, Donato Di Paola E, De Sarro A, Vidal MJ: Role of nitric oxide in the genesis of excitatory amino acid-induced seizures from the deep prepiriform cortex. Fundam Clin Pharmacol, 1991, 5, 503-511.
12. De Sarro G, Gareri P, Falconi U, De Sarro A: 7-Nitroindazole potentiates the antiseizure activity of some anticonvulsants in DBA/2 mice. Eur J Pharmacol, 2000, 394, 275-288.
13. 3H]-norepinephrine release from rat neocortical slices. Synapse, 2002, 45, 171-190.
14. Elger CE, Brodie MJ, Anhut H, Lee CM, Barrett JA: Pregabalin add-on treatment in patients with partial seizures: a novel evaluation of flexible-dose and fixed-dose treatment in a double-blind, placebo-controlled study. Epilepsia, 2005, 46, 1926-1936.
15. Errante LD, Petroff OA: Acute effects of gabapentin and pregabalin on rat forebrain cellular GABA, glutamate, and glutamine concentrations. Seizure, 2003, 12, 300-306.
16. French JA, Kugler AR, Robbins JL, Knapp LE, Garofalo EA: Dose-response trial of pregabalin adjunctive therapy in patients with partial seizures. Neurology, 2003, 60, 1631-1637.
17. Litchfield JT, Wilcoxon F: A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther, 1949, 96, 99-113.
18. Löscher W, Fassbender CP, Nolting B: The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. II. Maximal electroshock seizure models. Epilepsy Res, 1991, 8, 79-94.
19. Łuszczki JJ, Czuczwar M, Gawlik P, Sawiniec-Późniak G, Czuczwar K, Czuczwar SJ: 7-Nitroindazole potentiates the anticonvulsant action of some second-generation antiepileptic drugs in the mouse maximal electroshock-induced seizure model. J Neural Transm, 2006, 113, 1157-1168.
20. G-nitro-L-arginine on the anticonvulsant and acute adverse effects of some newer antiepileptic drugs in the maximal electroshock-induced seizures and chimney test in mice. Pharmacol Rep, 2006, 58, 955-960.
21. Łuszczki JJ, Ratnaraj N, Patsalos PN, Czuczwar SJ: Isobolographic analysis of interactions between loreclezole and conventional antiepileptic drugs in the mouse maximal electroshock-induced seizure model. Naunyn Schmiedebergs Arch Pharmacol, 2006, 373, 169-181.
22. Łuszczki JJ, Sacharuk A, Wojciechowska A, Andres MM, Dudra-Jastrzȩbska M, Mohamed M, Sawicka KM et al.: 7-Nitroindazole enhances dose-dependently the anticonvulsant activities of conventional antiepileptic drugs in the mouse maximal electroshock-induced seizure model. Pharmacol Rep, 2006, 58, 660-671.
23. G-nitro-L-Arginine on the anticonvulsive action of four second-generation antiepileptic drugs in pentetrazole-induced clonic seizures in mice. Pharmacol Rep, 2007, 59, 467-473.
24. Łuszczki JJ, Szadkowski M, Dudra-Jastrzȩbska M, Czernecki R, Filip D, Misiuta-Krzesińska M, Barcicka-Kłosowska B, Zwoliński J: 7-Nitroindazole does not affect the anti-convulsant action of gabapentin and tiagabine in pentylenetetrazole-induced seizures in mice. J Pre-Clin Clin Res, 2007, 1, 150-154.
25. Łuszczki JJ, Szadkowski M, Zadrożniak A, Wojda E, Dudra-Jastrzȩbska M, Andres-Mach M: No effect of 7-nitroindazole on the anticonvulsant action of vigabatrin and oxcarbazepine in pentylenetetrazole- induced seizures in mice. J Pre-Clin Clin Res, 2008, 2, 137-140.
26. G-nitro- L-arginine on the anticonvulsant activity of loreclezole in maximal electroshock-induced seizures in mice. J Pre-Clin Clin Res, 2007, 1, 146-149.
27. Micheva KD, Taylor CP, Smith SJ: Pregabalin reduces the release of synaptic vesicles from cultured hippocampal neurons. Mol Pharmacol, 2006, 70, 467-476.
28. Moncada S, Higgs EA: Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB J, 1995, 9, 1319-1330.
29. Smith SE, Man CM, Yip PK, Tang E, Chapman AG, Meldrum BS: Anticonvulsant effects of 7-nitroindazole in rodents with reflex epilepsy may result from L-arginine accumulation or a reduction in nitric oxide or L-citrulline formation. Br J Pharmacol, 1996, 119, 165-173.
30. Taylor CP, Angelotti T, Fauman E: Pharmacology and mechanism of action of pregabalin: the calcium channel α2-δ (alpha2-delta) subunit as a target for antiepileptic drug discovery. Epilepsy Res, 2007, 73, 137-150.
31. Tutka P, Łuszczki J, Kleinrok Z, Arent K, Wielosz M: Molsidomine enhances the protective activity of valproate against pentylenetetrazole-induced seizures in mice. J Neural Transm, 2002, 109, 455-466.
32. Vartanian MG, Radulovic LL, Kinsora JJ, Serpa KA, Vergnes M, Bertram E, Taylor CP: Activity profile of pregabalin in rodent models of epilepsy and ataxia. Epilepsy Res, 2006, 68, 189-205.
33. Venault P, Chapouthier G, de Carvalho LP, Simiand J, Morre M, Dodd RH, Rossier J: Benzodiazepine impairs and beta-carboline enhances performance in learning and memory tasks. Nature, 1986, 321, 864-866.
34. Warner G, Figgitt DP: Pregabalin: as adjunctive treatment of partial seizures. CNS Drugs, 2005, 19, 265-274.
35. Zadrożniak A, Wojda E, Wlaź A, Łuszczki JJ: Characterization of acute adverse-effect profiles of selected antiepileptic drugs in the grip-strength test in mice. Pharmacol Rep, 2009, 61, 737-742.